Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma.

H. Lythgoe,E. Baildam,M. Beresford,G. Cleary,L. McCann,C. Pain

DOI: https://doi.org/10.1093/rheumatology/kex382

2018-02-01

Rheumatology

Abstract:

What problem does this paper attempt to address?

Appliance-induced osteopenia of dentoalveolar bone in the rat: effect of reduced bone strains on serum bone markers and the multifunctional hormone leptin.

Jayaseelan K Vinoth,Kaval J Patel,Wei-Song Lih,Yian-San Seow,Tong Cao,Murray C Meikle

DOI: https://doi.org/10.1111/eos.12091

2013-01-01

European Journal Of Oral Sciences

Abstract:To understand, in greater detail, the molecular mechanisms regulating the complex relationship between mechanical strain and alveolar bone metabolism during orthodontic treatment, passive cross-arch palatal springs were bonded to the maxillary molars of 6-wk-old rats, which were killed after 4 and 8 d. Outcome measures included serum assays for markers of bone formation and resorption and for the multifunctional hormone leptin, and histomorphometry of the inter-radicular bone. The concentration of the bone-formation marker alkaline phosphatase (ALP) was significantly reduced at both time points in the appliance group, accompanied by a 50% reduction in inter-radicular bone volume; however, osteocalcin (bone Gla protein) levels remained unaffected. Bone collagen deoxypyridinoline (DPD) crosslinks increased 2.3-fold at 4 d only, indicating a transient increase in bone resorption; in contrast, the level of the osteoclast-specific marker, tartrate-resistant acid phosphatase 5b (TRACP 5b), was unchanged. Leptin levels closely paralleled ALP reductions at both time points, suggesting an important role in the mechanostat negative-feedback loop required to normalize bone mass. These data suggest that an orthodontic appliance, in addition to remodeling the periodontal ligament (PDL)-bone interface, may exert unexpected side-effects on the tooth-supporting alveolar bone, and highlights the importance of recognizing that bone strains can have negative, as well as positive, effects on bone mass.
The Effect of Alendronate on the Expression of Important Cell Factors in Osteoclasts

Qinghong Zhang,Mengtao Liu,Yi Zhou,Wei Liu,Juxiang Shen,Yanqing Shen,Li Liu

DOI: https://doi.org/10.3892/mmr.2013.1630

IF: 3.423

2013-01-01

Molecular Medicine Reports

Abstract:This study investigated the effects of alendronate (ALN) on critical cell factors in osteoclasts. RAW 264.7 cells were induced by sRANKL to change to mature osteoclasts. On the sixth day of incubation, the osteoclasts were treated with ALN at various concentrations and for different incubation times. The concentration groups included 10-5 M, 10-6 M and 10-7 M ALN, respectively. The cells were incubated for 0 (control group), 2, 4, 6 and 8 h for each dose group. The mRNA and protein expression of tartrate‑resistant acid phosphatase, carbonic anhydrase II, osteoclast‑associated receptor and FAS/FASL genes in osteoclasts was analyzed. A concentration- and time‑dependent decrease in the mRNA and protein expression levels of the five genes was observed, and no significant difference between the two control groups was observed (P>0.05). Notably, significant differences between any two experimental groups were observed (P<0.05). Thus, ALN significantly decreased the expression of critical factors involved in osteoclast function.
[Effect of the Bone Resorption Supernatant from RAW264.7 Osteoclast on the Osteogenic Activity of Mouse MC3T3-E1 Cell].

Li-li Chen,Kai Wang,Jie Zhang,Yan-min Wu

DOI: https://doi.org/10.3760/cma.j.issn.1002-0098.2012.01.012

2012-01-01

Abstract:OBJECTIVE:To investigate the effect of osteoclast bone resorption supernatants on the osteogenic activity of mouse MC3T3-E1 cell line.METHODS:Mouse RAW264.7 cell line was induced to osteoclast which was identified with tartrate resistant acid phosphatase (TRAP) staining and osteoclast specific gene detection. The differentiated RAW264.7 osteoclast was co-cultured with bovine milling bone specimen followed by toluidine blue staining. Then mouse MC3T3-E1 cell was cultured with supernatant from the osteoclast bone absorbent model. Methyl thiazolyl tetrazolium (MTT) method, alizarin red S staining, enzyme-linked immunosorbent assay detection of osteocalcin, and reverse transcriptase polymerase chain reaction detection were adopted to investigate the proliferation, calcification and osteogenic activity of MC3T3-E1 cells.RESULTS:TRAP staining, osteoclast specific gene detection and toluidine blue staining all indicated that RAW264.7 cell could be differentiated into functioning osteoclast. The supernatant from the osteoclast bone absorbent model could inhibit the proliferation of MC3T3-E1 cells, with the A value between 0.062 ± 0.004 and 0.405 ± 0.033 (P < 0.05). It could also increase the formation of calcification nods, promote the osteocalcin level which peaked with the tenth day's supernatant at a level of (2.965 ± 0.047) µg/L, as well as enhance the transcription of the alkaline phosphatase and Runt related transcription factor 2 gene.CONCLUSIONS:RAW264.7 osteoclast bone absorbent supernatant might influence the osteogenic activity of osteoblast-like cell by inhibiting proliferation, promoting differentiation and calcification.
Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

Chen Lili,Huang Mei,Lei Lihong,Wu Yanmin

DOI: https://doi.org/10.16016/j.1000-5404.2013.04.023

2013-01-01

Abstract:Objective To investigate the potential role of a system containing osteoprotegerin(OPG),receptor activator of NF-κB ligand(RANKL),and receptor activator of nuclear factor-kappa B(RANK),also as,OPG/RANKL/RANK system in the resorption and remodeling mechanisms of alveolar bone.Methods Mouse RAW264.7 cell line was induced to osteoclasts in vitro,and mouse MC3T3-E1 cell line was treated with bone resorption supernatant.The control cells was cultured with regular medium.The expression levels of OPG,RANKL and RANK in the cells was detected by immunofluorescence assay.Thirty 8-week-old male SD rats were used to establish the alveolar bone resorption model with the injection of E-LPS.Immunohistochemical S-P method was used to investigate the expression of OPG,RANKL and RANK in the animal model.Results The expression of OPG in MC3T3-E1 cells was up-regulated after 7 days' treatment with bone resorption supernatant than in control cells(29.636±5.652 vs 15.568±1.229,P<0.01),while,the RANKL expression was down-regulated(6.806±1.738 vs 18.082±2.732,P<0.01).The ratio of OPG to RANKL was up-regulated too(P<0.05).The OPG level in periodontal tissues of rats was decreased compared with the tissue without resorption.But the expression of RANKL was increased.Conclusion OPG/RANKL/RANK system is involved in the bone resorption and remodeling.Osteoclast bone absorbent supernatants might affect the ratio of OPG to RANKL by regulating of the differentiation and activity of osteoblast-like cells,and thus regulate the dynamic balance of bone formation and resorption.
PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.

Li-Li Chen,Mei Huang,Jing-Yi Tan,Xiao-Tao Chen,Li-Hong Lei,Yan-Min Wu,Di-Ya Zhang

DOI: https://doi.org/10.1089/ten.tea.2012.0469

IF: 4.08

2013-01-01

Tissue Engineering Part A

Abstract:This study aimed to investigate the ability of osteoclasts during bone resorption activities to regulate the differentiation and calcification of osteoblast precursor cells. The bone resorption model was established using in vitro cortical bone slices and mouse RAW264.7 cells, which were differentiated into osteoclasts by stimulation with the receptor activator of nuclear factor-B ligand and macrophage colony-stimulating factor. Tartrate-resistant acid phosphatase (TRAP) staining, reverse transcriptase-polymerase chain reaction (RT-PCR), and scanning electron microscopy (SEM) were used to detect osteoclast differentiation. The osteoblast precursor cell line MC3T3-E1 was cultured with the bone resorption supernatant (BRS). Involvement of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway in osteogenesis was evaluated by Western blotting, RT-PCR, and ELISA analysis of markers of the early (runt-related transcription factor-2 and alkaline phosphatase) and late (osteocalcin [OCN]) stages of osteogenesis, and Alizarin Red S staining of matrix mineralization. TRAP staining, RT-PCR, and SEM analysis demonstrated the successful establishment of the bone resorption model. Osteoclast BRS effectively increased the differentiation and calcification of MC3T3-E1 cells. Western blot analysis indicated that the BRS enhanced AKT and p-AKT expression levels in MC3T3-E1 cells. Following AKT2 knockdown and treatment with the PI3K/AKT pathway inhibitor LY294002, the expression of OCN in MC3T3-E1 cells was decreased (p<0.05), as was the calcification area (p<0.05). The data obtained in this study indicated that the osteoclast bone resorption medium promoted the differentiation and calcification of MC3T3-E1 cells and that the PI3K/AKT pathway played a role in this process.
Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage

Edith M. Gardiner,Paul A. Baldock,Gethin P. Thomas,Natalie A. Sims,N. Kathryn Henderson,Bruce Hollis,Christopher P. White,Kathryn L. Sunn,Nigel A. Morrison,William R. Walsh,John A. Eisman

DOI: https://doi.org/10.1096/fj.99-1075com

2000-10-01

The FASEB Journal

Abstract:The microarchitecture of bone is regulated by complex interactions between the bone-forming and resorbing cells, and several compounds regulate both actions. For example, vitamin D, which is required for bone mineralization, also stimulates bone resorption. Transgenic mice overexpressing the vitamin D receptor solely in mature cells of the osteoblastic bone-forming lineage were generated to test the potential therapeutic value of shifting the balance of vitamin D activity in favor of bone formation. Cortical bone was 5% wider and 15% stronger in these mice due to a doubling of periosteal mineral apposition rate without altered body weight or calcium homeostatic hormone levels. A 20% increase in trabecular bone volume in transgenic vertebrae was also observed, unexpectedly associated with a 30% reduction in resorption surface rather than greater bone formation. These findings indicate anabolic vitamin D activity in bone and identify a previously unknown pathway from mature osteoblastic cells to inhibit osteoclastic bone resorption, counterbalancing the known stimulatory action through immature osteoblastic cells. A therapeutic approach that both stimulates cortical anabolic and inhibits trabecular resorptive pathways would be ideal for treatment of osteoporosis and other osteopenic disorders.

cell biology,biochemistry & molecular biology,biology
Development of the psychological impact of tinnitus interview: a clinician-administered measure of tinnitus-related distress.

J. Henry,M. Kangas,P. Wilson

Abstract:The development of valid and reliable methods for assessing psychological aspects of tinnitus continues to be an important goal of research. Such assessment methods are potentially useful in clinical and research contexts. Existing self-report measures have a number of disadvantages, and so a need exists to develop a form of assessment that is less open to response bias and the effects of experimental demand. A new approach, the Psychological Impact of Tinnitus Interview (PITI), is described, and some preliminary data on its psychometric properties are reported. The results suggest that the PITI is capable of providing a measure of separate, relatively independent dimensions of tinnitus-related distress--namely, sleep difficulties, general distress, mood, suicidal aspects, and avoidance of or interference with normal activities. This method may lead to more refined measures of these dimensions of tinnitus-related psychological difficulties. The PITI should be regarded as a promising assessment tool for use in experimental settings, pending further work on its content, coding method, and administration.
Heterodimeric BMP-2/7 Antagonizes the Inhibition of All-Trans Retinoic Acid and Promotes the Osteoblastogenesis

Wenjuan Bi,Zhiyuan Gu,Yuanna Zheng,Xiao Zhang,Jing Guo,Gang Wu

DOI: https://doi.org/10.1371/journal.pone.0078198

IF: 3.7

2013-01-01

PLoS ONE

Abstract:Objectives Hypervitaminosis A and alcoholism can result in a low mineral density and compromised regenerative capacity of bone, thus delaying implant osteointegration. The inhibitory effect of all-trans retinoic acid on osteoblastogenesis is considered to be one of the mechanisms. We hypothesized that heterodimeric bone morphogenetic protein-2/7 could antagonize all-trans retinoic acid and enhance osteoblastogenesis, with an aim to accelerate and enhance bone regeneration and implant osteointegration. Materials and Methods We applied 5 ng/ml or 50 ng/ml bone morphogenetic protein-2/7 to restore the osteoblastogenesis of pre-osteoblasts (MC3T3-E1 cell line) that was inhibited by 1 µM all-trans retinoic acid. We evaluated the efficacy by assessing cell numbers (proliferation), alkaline phosphatase activity (a marker for early differentiation), osteocalcin (a marker for late differentiation), calcium deposition (a marker for final mineralization) and the expression of osteoblastogenic genes (such as Runx2, Collagen Ia, alkaline phosphatase and osteocalcin) at different time points. Results All-trans retinoic acid significantly inhibited the expression of all the tested osteoblastogenic genes and proteins except alkaline phosphatase activity. In the presence of ATRA, 50 ng/ml bone morphogenetic protein-2/7 not only completely restored but also significantly enhanced all the osteoblastogenic genes and proteins. On the 28th day, mineralization was completely inhibited by all-trans retinoic acid. In contrast, 50 ng/ml BMP-2/7 could antagonize ATRA and significantly enhance the mineralization about 2.5 folds in comparison with the control treatment (no ATRA, no BMP2/7). Conclusions Heterodimeric bone morphogenetic protein-2/7 bears a promising application potential to significantly promote bone regeneration and implant osteointegration for the patients with hypervitaminosis A and alcoholism.
Vitamin D receptor expression in human bone tissue and dose-dependent activation in resorbing osteoclasts

Allahdad Zarei,Alireza Morovat,Kassim Javaid,Cameron P Brown

DOI: https://doi.org/10.1038/boneres.2016.30

IF: 12.7

2016-10-11

Bone Research

Abstract:The effects of vitamin D on osteoblast mineralization are well documented. Reports of the effects of vitamin D on osteoclasts, however, are conflicting, showing both inhibition and stimulation. Finding that resorbing osteoclasts in human bone express vitamin D receptor (VDR), we examined their response to different concentrations of 25-hydroxy vitamin D3 [25(OH)D3] (100 or 500 nmol·L−1) and 1,25-dihydroxy vitamin D3 [1,25(OH)2D3] (0.1 or 0.5 nmol·L−1) metabolites in cell cultures. Specifically, CD14+ monocytes were cultured in charcoal-stripped serum in the presence of receptor activator of nuclear factor kappa-B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). Tartrate-resistant acid phosphatase (TRAP) histochemical staining assays and dentine resorption analysis were used to identify the size and number of osteoclast cells, number of nuclei per cell and resorption activity. The expression of VDR was detected in human bone tissue (ex vivo) by immunohistochemistry and in vitro cell cultures by western blotting. Quantitative reverse transcription-PCR (qRT-PCR) was used to determine the level of expression of vitamin D-related genes in response to vitamin D metabolites. VDR-related genes during osteoclastogenesis, shown by qRT-PCR, was stimulated in response to 500 nmol·L−1 of 25(OH)D3 and 0.1–0.5 nmol·L−1 of 1,25(OH)2D3, upregulating cytochrome P450 family 27 subfamily B member 1 (CYP27B1) and cytochrome P450 family 24 subfamily A member 1 (CYP24A1). Osteoclast fusion transcripts transmembrane 7 subfamily member 4 (tm7sf4) and nuclear factor of activated T-cell cytoplasmic 1 (nfatc1) where downregulated in response to vitamin D metabolites. Osteoclast number and resorption activity were also increased. Both 25(OH)D3 and 1,25(OH)2D3 reduced osteoclast size and number when co-treated with RANKL and M-CSF. The evidence for VDR expression in resorbing osteoclasts in vivo and low-dose effects of 1,25(OH)2D3 on osteoclasts in vitro may therefore provide insight into the effects of clinical vitamin D treatments, further providing a counterpoint to the high-dose effects reported from in vitro experiments.

cell & tissue engineering
All-trans retinoic acid modulates Wnt3A-induced osteogenic differentiation of mesenchymal stem cells via activating the PI3K/AKT/GSK3β signalling pathway

Shuang Zhang,Xiaoting Chen,Yan Hu,Jin Wu,Qing Cao,Shuyan Chen,Yanhong Gao

DOI: https://doi.org/10.1016/j.mce.2015.12.018

2016-02-15

Abstract:Osteogenic differentiation of mesenchymal stem cells (MSCs) is a vital process for the maintenance of healthy bone tissue and is mediated by numerous factors. Canonical Wnt signalling is essential for MSC osteogenic differentiation, and it interacts with several nuclear receptors, including the retinoic acid receptor, vitamin D receptor, and glucocorticoid receptor. Here, we explored whether Wnt3A and all-trans-retinoic acid (ATRA) play synergistic roles in MSC osteogenic differentiation. We found that ATRA potentiated the Wnt3A-induced expression of early and late osteogenic markers as well as matrix mineralization and further confirmed the phenomena using foetal limb explant culture and MSC implantation experiments. Mechanistically, ATRA cooperated with Wnt3A to induce β-catenin translocation from cell-cell contacts into the cytosol and nucleus, thereby activating Wnt/β-catenin signalling. Additionally, Wnt3A attenuated ATRA-induced Cyp26a1 expression, inhibiting the degradation of ATRA into its oxidative forms. β-catenin silencing abolished the stimulatory effect of ATRA on Wnt3A-induced alkaline phosphatase (ALP) activity and reversed its inhibitory effect on Cyp26a1 expression. Furthermore, ATRA and Wnt3A synergistically promoted AKT phosphorylation, enhancing β-catenin-dependent transcription through GSK3β inhibition or direct β-catenin phosphorylation at Ser552. This event was largely abolished by LY294002 pre-treatment, suggesting that ATRA and Wnt3A at least partially promote osteogenic differentiation via activating the PI3K/AKT/GSK3β signalling pathway. Thus, crosstalk between the Wnt/β-catenin and retinoic acid signalling pathways may be an effective therapeutic target for bone diseases, such as osteoporosis.
The effect of TGF-β on osteoclast differentiation in vitro

Zhao Yuming,Ge Lihong

DOI: https://doi.org/10.3969/j.issn.1001-3733.2006.01.010

2006-01-01

Abstract:Objective:To investigate the effect of TGF-β on osteoclast differentiation in primary murine bone marrow cell culture in the presence of receptor activator of NF-κB Ligand(RANKL) and macrophage colony stimulating facotr(M-CSF).Methods:M-CSF-dependent bone marrow cells were isolated from 5~6 weeks old mice,and cultured in the presence of RANKL at 30 ng/ml and M-CSF at 25 ng/ml with or without 1 ng/ml of TGF-β for 4 and 9 days respectively.TRAP positive multinucleated cells and resorption pits on dentine slices were counted under light microscope.Results:TRAP positive multinucleated cells were induced from murine bone marrow cell cultures with both RANKL and M-CSF,and these cells formed resorption pits on dentine slices.The number of TRAP positive multinucleated cells and resorption pits were significantly increased by 1 ng/ml of TGF-β(P<0.01).Conclusion: TGF-β can augment osteoclast formation and function,which may partially account for the bone destruction under inflammation.
Present use of five-day wards.

R. Davies,K. Cliff,W. Waters

DOI: https://doi.org/10.1136/bmj.282.6282.2118

1981-06-27

British Medical Journal

Abstract:A survey of five-day wards serving medical and surgical specialties indicated that 30 such units were operating in England in 1979. Six mixed surgical specialty, eight mixed specialty (medicine and surgery), four medical investigation, and 12 single specialty wards had opened since 1969. There was a varied, and often low, use of these wards. Nurse-staffing levels and allocation of operating theatre time also varied considerably. In busy wards nurse-staffing levels were high and access to operating theatre time reasonable. Medical investigation wards showed some of the highest levels of occupancy and throughput. The potential savings and service improvements that can result from five-day wards have yet to be realised on a wide scale.
All-trans retinoic acid inhibits the osteogenesis of periodontal ligament stem cells by promoting IL-1β production via NF-κB signaling

Li Guo,Yan Zhang,Honghong Liu,Qianyu Cheng,Shiyao Yang,Deqin Yang

DOI: https://doi.org/10.1016/j.intimp.2022.108757

IF: 5.714

2022-07-01

International Immunopharmacology

Abstract:All-trans retinoic acid (ATRA), a main derivative of vitamin A, has been shown to affect the osteogenic differentiation of mesenchymal stem cells (MSCs). Periodontal ligament stem cells (PDLSCs) possess characteristics of MSC and show strong potential for use in periodontal tissue restoration. However, the effect of ATRA on the osteogenic differentiation of PDLSCs remains unclear. In this study, we explored the effect of ATRA on the PDLSCs osteogenic differentiation. PDLSCs were harvested from the periodontal membrane and treated with or without ATRA. CCK-8 and cell cycle analysis were used to evaluate PDLSC proliferation. PDLSC migration was assessed by scratch tests. qRT-PCR, western blotting, alkaline phosphatase staining, alizarin red staining and calcium quantification were performed to estimate the PDLSCs osteogenic differentiation capability and RNA sequencing to select differentially expressed genes (DEGs). Expression and activation of signaling elements were assessed by qRT-PCR, western blotting and immunofluorescence. Finally, we discovered that ATRA repressed the migration, proliferation, and osteogenesis ability of PDLSCs. RNA sequencing revealed 493 DEGs. Levels of interleukin-1β (IL-1β) were increased at varied time points after ATRA treatment. The inhibitive influence of ATRA on the osteogenesis of PDLSCs was partially reversed after neutralizing IL-1β. In addition, IL-1β levels were significantly attenuated by nuclear factor-κB (NF-κB) inhibitor BAY11-7082 and NLRP3 inhibitor MCC950. Taken together, our results demonstrate that ATRA disrupts the osteogenesis and mineralization of PDLSCs by promoting IL-1β expression via activating NF-κB signaling and NLRP3 inflammasome, which may offer a new method for improving the ATRA-induced disruption of osteoblast differentiation.

pharmacology & pharmacy,immunology
Bone Morphogenetic Protein-15

Fumio Otsuka,Z. Yao,T. Lee,Shin Yamamoto,G. Erickson,S. Shimasaki

DOI: https://doi.org/10.1074/jbc.M007428200

IF: 5.485

2000-12-15

Journal of Biological Chemistry

Abstract:In developing ovarian follicles, the regulation of cell proliferation and differentiation is tightly coordinated. Precisely how this coordination is achieved is unknown, but recent observations have suggested that molecules emitted by the oocyte are involved in the process. The newly discovered oocyte-specific growth factor, bone morphogenetic protein-15 (BMP-15), is one such molecule. At present, nothing is known about the target cells and biological functions of BMP-15. To fill this gap in our knowledge, recombinant BMP-15 and its antibody were produced and used to determine BMP-15 expression and bioactivity. BMP-15 mRNA and protein were shown to be co-expressed in oocytes throughout folliculogenesis, supporting the idea that BMP-15 is a physiological regulator of follicle cell proliferation and/or differentiation. To test this, we used primary cultures of rat granulosa cells (GCs). We found that BMP-15 is a potent stimulator of GC proliferation, and importantly, the mitogenic effect was follicle-stimulating hormone (FSH)-independent. By contrast, BMP-15 alone had no effect on steroidogenesis. However, it produced a marked decrease in FSH-induced progesterone production, but had no effect on FSH-stimulated estradiol production. This result indicates that BMP-15 is a selective modulator of FSH action. In summary, this study identifies GCs as the first target cells for BMP-15. Moreover, it identifies the stimulation of GC proliferation and the differential regulation of two crucial steroid hormones as the first biological functions of BMP-15. Significantly, BMP-15 is the first growth factor that can coordinate GC proliferation and differentiation in a way that reflects normal physiology.
Antagonistic And Synergistic Effects Of Bone Morphogenetic Protein 2/7 And All- Trans Retinoic Acid On The Osteogenic Differentiation Of Rat Bone Marrow Stromal Cells

Wenjuan Bi,Zhiyuan Gu,Yuanna Zheng,Limin Wang,Jing Guo,Gang Wu

DOI: https://doi.org/10.1111/dgd.12090

2013-01-01

Abstract:The osteogenesis of bone marrow stromal cells (BMSCs) is of paramount importance for the repair of large-size bone defects, which may be compromised by the dietary-accumulated all-trans retinoic acid (ATRA). We have shown that heterodimeric bone morphogenetic protein 2/7 (BMP2/7) could induce bone regeneration in a significantly higher dose-efficiency in comparison with homodimeric BMPs. In this study, we evaluated the effects of ATRA and BMP2/7 on the proliferation, differentiation, mineralization and osteogenic genes. ATRA and BMP2/7 exhibited both antagonistic and synergistic effects on the osteogenesis of BMSCs. ATRA significantly inhibited proliferation and expression of osteocalcin but enhanced the activity of alkaline phosphatase of BMSCs. On day 21, 50ng/mL BMP2/7 could antagonize the inhibitive effects of ATRA and significantly enhance osteogenesis of BMSCs. These findings suggested a promising application potential of heterodimeric BMP2/7 in clinic to promote bone regeneration for the cases with dietary accumulated ATRA.
Class A Scavenger Receptor Exacerbates Osteoclastogenesis by an Interleukin-6-Mediated Mechanism through ERK and JNK Signaling Pathways

Shuyu Guo,Yuanyuan Ni,Jingjing Ben,Yang Xia,Tingting Zhou,Dongyue Wang,Jieli Ni,Hui Bai,Lin Wang,Junqing Ma,Qi Chen

DOI: https://doi.org/10.7150/ijbs.14654

2016-01-01

International Journal of Biological Sciences

Abstract:Osteoclasts originate from bone marrow monocyte/macrophage lineage cells, which are important for bone health. Class A scavenger receptor (SR-A) is a multifunctional molecule that functions during differentiation of monocyte into macrophages and osteoclasts. To further characterize the role of SR-A in osteoclasts, we used the murine tooth movement model (TM) and the murine anterior cruciate ligament transection model of osteoarthritis (ACLT OA). In these two models the bones involved are of different origin and have different properties. Bone resorption was decreased in SR-A-/- mice compared to SR-A+/+ mice. Further evaluation showed that the number of multinucleated osteoclasts in SR-A-/- mice, compared to SR-A+/+ mice, was significantly decreased both in vivo and in vitro. The levels of interleukin-6 (IL-6) produced by osteoclasts were reduced in SR-A-/- mice compared to SR-A+/+ mice. In the in vitro marrow-derived osteoclast formation assay and in both mouse models, osteoclastogenesis was restored to normal in SR-A-/- mice by administration of recombinant murine IL-6. Moreover, neutralization of IL-6 reduced the number of osteoclasts formed in SR-A+/+ mice of TM model. Both extracellular signal-regulated kinase (ERK) and c-Jun N-terminal protein kinase (JNK), but not p38, signaling pathways were downregulated in receptor activator of nuclear factor-κB ligand (RANKL)-stimulated SR-A-/- osteoclasts. Importantly, when treated with either ERK or JNK inhibitor, the numbers of osteoclasts generated from RANKL-induced bone marrow derived-macrophages of SR-A+/+ mice, and their IL-6 production, were significantly decreased. This suggests that SR-A activates the ERK and JNK signaling pathways, and promotes production of IL-6 by osteoclasts to further stimulate osteoclast formation.

biochemistry & molecular biology
Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D

Junichi Kikuta,Shunsuke Kawamura,Fumie Okiji,Mai Shirazaki,Sadaoki Sakai,Hitoshi Saito,Masaru Ishii

DOI: https://doi.org/10.1073/pnas.1218799110

IF: 11.1

2013-04-08

Proceedings of the National Academy of Sciences

Abstract:The migration and positioning of osteoclast precursor monocytes are controlled by the blood-enriched lipid mediator sphingosine-1-phosphate (S1P) and have recently been shown to be critical points of control in osteoclastogenesis and bone homeostasis. Here, we show that calcitriol, which is the hormonally active form of vitamin D, and its therapeutically used analog, eldecalcitol, inhibit bone resorption by modulating this mechanism. Vitamin D analogs have been used clinically for treating osteoporosis, although the mode of its pharmacologic action remains to be fully elucidated. In this study, we found that active vitamin D reduced the expression of S1PR2, a chemorepulsive receptor for blood S1P, on circulating osteoclast precursor monocytes both in vitro and in vivo. Calcitriol- or eldecalcitol-treated monocytoid RAW264.7 cells, which display osteoclast precursor-like properties, migrated readily to S1P. Concordantly, the mobility of circulating CX 3 CR1 + osteoclast precursor monocytes was significantly increased on systemic administration of active vitamin D. These results show a mechanism for active vitamin D in controlling the migratory behavior of circulating osteoclast precursors, and this action should be conducive to limiting osteoclastic bone resorption in vivo.

multidisciplinary sciences
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

Jonathan Lam,Sunao Takeshita,Jane E. Barker,Osami Kanagawa,F. Patrick Ross,Steven L. Teitelbaum

DOI: https://doi.org/10.1172/jci11176

IF: 19.456

2000-12-15

Journal of Clinical Investigation

Abstract:While TNF-alpha is pivotal to the pathogenesis of inflammatory osteolysis, the means by which it recruits osteoclasts and promotes bone destruction are unknown. We find that a pure population of murine osteoclast precursors fails to undergo osteoclastogenesis when treated with TNF-alpha alone. In contrast, the cytokine dramatically stimulates differentiation in macrophages primed by less than one percent of the amount of RANKL (ligand for the receptor activator of NF-kappaB) required to induce osteoclast formation. Mirroring their synergistic effects on osteoclast differentiation, TNF-alpha and RANKL markedly potentiate NF-kappaB and stress-activated protein kinase/c-Jun NH(2)-terminal kinase activity, two signaling pathways essential for osteoclastogenesis. In vivo administration of TNF-alpha prompts robust osteoclast formation in chimeric animals in which ss-galactosidase positive, TNF-responsive macrophages develop within a TNF-nonresponsive stromal environment. Thus, while TNF-alpha alone does not induce osteoclastogenesis, it does so both in vitro and in vivo by directly targeting macrophages within a stromal environment that expresses permissive levels of RANKL. Given the minuscule amount of RANKL sufficient to synergize with TNF-alpha to promote osteoclastogenesis, TNF-alpha appears to be a more convenient target in arresting inflammatory osteolysis.

medicine, research & experimental
Macrophages Promote Osteoblastic Differentiation In Vivo: Implications in Fracture Repair and Bone Homeostasis

Linda Vi,Gurpreet S Baht,Heather Whetstone,Adeline Ng,Qingxia Wei,Raymond Poon,Sivakami Mylvaganam,Marc Grynpas,Benjamin A Alman

DOI: https://doi.org/10.1002/jbmr.2422

IF: 6.39

2015-05-18

Journal of Bone and Mineral Research

Abstract:Macrophages are activated in inflammation and during early phases of repair processes. Interestingly, they are also present in bone during development, but their function during this process is unclear. Here, we explore the function of macrophages in bone development, growth, and repair using transgenic mice to constitutively or conditionally deplete macrophages. Depletion of macrophages led to early skeletal growth retardation and progressive osteoporosis. By 3 months of age, macrophage-deficient mice displayed a 25% reduction in bone mineral density and a 70% reduction in the number of trabecular bone compared to control littermates. Despite depletion of macrophages, functional osteoclasts were still present in bones, lining trabecular bone and the endosteal surface of the cortical bone. Furthermore, ablation of macrophages led to a 60% reduction in the number of bone marrow mesenchymal progenitor cells and a decrease in the ability of these cells to differentiate to osteoblasts. When macrophages were depleted during fracture repair, bone union was impaired. Calluses from macrophage-deficient animals were smaller, and contained less bone and more fibrotic tissue deposition. Taken together, this shows that macrophages are crucial for maintaining bone homeostasis and promoting fracture repair by enhancing the differentiation of mesenchymal progenitors.

endocrinology & metabolism
Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models

Georg Schett,Scot Middleton,Brad Bolon,Marina Stolina,Heather Brown,Li Zhu,Jim Pretorius,Debra J Zack,Paul Kostenuik,Ulrich Feige

DOI: https://doi.org/10.1002/art.21021

Abstract:Objective: To investigate whether the bone-preserving effects of a RANKL antagonist or a tumor necrosis factor (TNF) antagonist could be further improved by the addition of a bone anabolic agent in inflammatory arthritis. Methods: Lewis rats with either adjuvant-induced arthritis (AIA) or collagen-induced arthritis (CIA) were treated for 10 days with PEGylated soluble tumor necrosis factor receptor type I (PEG sTNFRI), interleukin-1 receptor antagonist (IL-1Ra), osteoprotegerin (OPG), parathyroid hormone (PTH), or combinations of these agents starting on day 4 after disease onset. Treatment effects were assessed clinically, radiologically, and histologically, and by morphometry for the extent of paw swelling, bone erosive changes, and synovial inflammation. Results: Paw swelling and synovial inflammation were significantly inhibited by PEG sTNFRI in AIA and CIA, and by IL-1Ra in CIA. OPG and PTH had no significant effect on these parameters. Analysis of bone erosion revealed a significant bone-sparing effect of monotherapy with PEG sTNFRI or OPG in both models, whereas IL-1Ra was only effective in CIA. PTH treatment alone did not show a bone-protective effect in either model. With the combination of PEG sTNFRI and PTH, erosion scores (-74% in AIA and -61% in CIA versus controls) were significantly lower than those elicited by PEG sTNFRI alone (-41% and -29%, respectively, versus controls). Similar results were also obtained with the combination of OPG and PTH (-88% in AIA and -73% in CIA, compared with -70% and -55%, respectively, with OPG monotherapy). Coadministration of IL-1Ra and PTH had no synergistic bone-sparing effect. Morphometric analysis revealed that the addition of PTH to PEG sTNFRI or OPG resulted in higher bone volume and higher osteoblast numbers in both AIA and CIA. Conclusion: The bone-protective effects resulting from RANKL or TNF antagonism can be further improved by the addition of a bone anabolic agent.

Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma.

Appliance-induced osteopenia of dentoalveolar bone in the rat: effect of reduced bone strains on serum bone markers and the multifunctional hormone leptin.

The Effect of Alendronate on the Expression of Important Cell Factors in Osteoclasts

[Effect of the Bone Resorption Supernatant from RAW264.7 Osteoclast on the Osteogenic Activity of Mouse MC3T3-E1 Cell].

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.

Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage

Development of the psychological impact of tinnitus interview: a clinician-administered measure of tinnitus-related distress.

Heterodimeric BMP-2/7 Antagonizes the Inhibition of All-Trans Retinoic Acid and Promotes the Osteoblastogenesis

Vitamin D receptor expression in human bone tissue and dose-dependent activation in resorbing osteoclasts

All-trans retinoic acid modulates Wnt3A-induced osteogenic differentiation of mesenchymal stem cells via activating the PI3K/AKT/GSK3β signalling pathway

The effect of TGF-β on osteoclast differentiation in vitro

Present use of five-day wards.

All-trans retinoic acid inhibits the osteogenesis of periodontal ligament stem cells by promoting IL-1β production via NF-κB signaling

Bone Morphogenetic Protein-15

Antagonistic And Synergistic Effects Of Bone Morphogenetic Protein 2/7 And All- Trans Retinoic Acid On The Osteogenic Differentiation Of Rat Bone Marrow Stromal Cells

Class A Scavenger Receptor Exacerbates Osteoclastogenesis by an Interleukin-6-Mediated Mechanism through ERK and JNK Signaling Pathways

Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D

TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

Macrophages Promote Osteoblastic Differentiation In Vivo: Implications in Fracture Repair and Bone Homeostasis

Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models